-
N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy]acetamide hydrate
-
ChemBase ID:
153701
-
Molecular Formular:
C26H28N6O5
-
Molecular Mass:
504.53772
-
Monoisotopic Mass:
504.21211803
-
SMILES and InChIs
SMILES:
CCCn1c2c(c(=O)n(c1=O)CCC)nc([nH]2)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N.O
Canonical SMILES:
CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N.O
InChI:
InChI=1S/C26H26N6O4.H2O/c1-3-13-31-24-22(25(34)32(14-4-2)26(31)35)29-23(30-24)18-7-11-20(12-8-18)36-16-21(33)28-19-9-5-17(15-27)6-10-19;/h5-12H,3-4,13-14,16H2,1-2H3,(H,28,33)(H,29,30);1H2
InChIKey:
ZACJDWOPQROWIK-UHFFFAOYSA-N
-
Cite this record
CBID:153701 http://www.chembase.cn/molecule-153701.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy]acetamide hydrate
|
|
|
|
|
IUPAC Traditional name
|
|
N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)phenoxy]acetamide hydrate
|
|
|
|
|
Synonyms
|
|
8-[4-[((4-Cyanophenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)xanthine hydrate
|
|
MRS 1754 hydrate
|
|
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
10.743323
|
H Acceptors
|
6
|
H Donor
|
2
|
LogD (pH = 5.5)
|
3.5854185
|
LogD (pH = 7.4)
|
3.5853276
|
Log P
|
3.5855021
|
Molar Refractivity
|
143.8183 cm3
|
Polarizability
|
50.61281 Å3
|
Polar Surface Area
|
131.42 Å2
|
Rotatable Bonds
|
9
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
M6316
|
Biochem/physiol Actions MRS 1754 hydrate is a potent A2B adenosine receptor antagonist. Legal Information Manufactured and sold under license from Adenosine Therapeutics LLC. |
PATENTS
PATENTS
PubChem Patent
Google Patent